The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions
Open accessAbstract
Macroscopic sampling of multiple sclerosis lesions in the brain tends to find chronic lesions. For a better understanding of the dynamics of the multiple sclerosis disease process, research into new and developing lesions is of great interest. As MRI in vivo effectively demonstrates lesions in multiple sclerosis patients, we have applied it to unfixed post-mortem brain slices to identify abnormalities, in order to obtain a higher yield of active lesions. The Netherlands Brain Bank organized the rapid autopsy of 29 multiple sclerosis patients. The brain was cut in 1 cm coronal slices. One or two slices were subjected to T(1)- and T(2)-weighted MRI, and then cut at the plane of the MRI scan into 5 mm thick opposing sections. Areas of interest were identified based on the MRI findings and excised. One half was fixed in 10% formalin and paraffin-embedded, and the corresponding area in the adjacent half was snap-frozen in liquid nitrogen. In total, 136 out of 174 brain tissue samples could be matched with the abnormalities seen on T(2)-weighted MRIs. The stage of lesional development was determined (immuno) histochemically. For 54 MRI-detectable samples, it was recorded whether they were macroscopically detectable, i.e. visible and/or palpable. Histopathological analysis revealed that 48% of the hyperintense areas seen on T(2)-weighted images represented active lesions, including lesions localized in the normal appearing white matter, without apparent loss of myelin but nevertheless showing a variable degree of oedema, small clusters of microglial cells with enhanced major histocompatibility complex class II antigen, CD45 and CD68 antigen expression and a variable number of perivascular lymphocytes around small blood vessels [designated as (p)reactive lesions]. From the macroscopically not-visible/not-palpable MRI-detected abnormalities, 58% were (p)reactive lesions and 21% contained active demyelinating lesions. In contrast, visible and/or palpable brain tissue samples mainly contained chronic inactive lesions. We conclude that MRI-guided sampling of brain tissue increases the yield of active multiple sclerosis lesions, including active demyelinating and (p)reactive lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
van Walderveen, M. A. A., Kamphorst, W., Scheltens, P., van Waesberghe, J. H. T. M., Ravid, R., Valk, J., Polman, C. H., & Barkhof, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1282 · Cited by 656
Self-citationThe role of magnetic resonance techniques in understanding and managing multiple sclerosis
Miller, D. (1998) · Brain · doi:10.1093/brain/121.1.3 · Cited by 556
Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS
Van Der Valk, P., & De Groot, C. J. A. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00217.x · Cited by 306
Self-citationPathogenesis of tissue injury in MS lesions
Trapp, B. D., Bö, L., Mörk, S., & Chang, A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00081-8 · Cited by 259
Bö, L., Mörk, S., Kong, P. A., Nyland, H., Pardo, C. A., & Trapp, B. D. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90075-2 · Cited by 256
Multiple sclerosis: A serial study using MRI in relapsing patients
Isaac, C., B. Li, D. K., Genton, M., Jardine, C., Grochowski, E., Palmer, M., Kastrukoff, L. F., Oger, J., & Paty, D. W. (1988) · Neurology · doi:10.1212/wnl.38.10.1511 · Cited by 189
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines
Ransohoff, R. M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00082-x · Cited by 163
Groot, C. J. A. D., Montagne, L., Barten, A. D., Sminia, P., & van der Valk, P. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199902000-00007 · Cited by 128
Ulvestad, E., Williams, K. C., Mørk, S. J., Antel, J. P., & Nyland, H. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00008 · Cited by 126
Microglia-derived macrophages in early multiple sclerosis plaques
Li, H., Cuzner, M. L., & Newcombe, J. (1996) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1996.tb00896.x · Cited by 111
Cited by
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain
Schmierer, K., Scaravilli, F., Altmann, D. R., Barker, G. J., & Miller, D. H. (2004) · Annals of Neurology · doi:10.1002/ana.20202 · Cited by 776
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
The clinico-radiological paradox in multiple sclerosis revisited
Barkhof, F. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00003 · Cited by 726
An updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692
“There is an emerging body of work, suggesting that the forerunners of MS lesions, so-called pre-lesional changes or pre-active lesions, may be detected both radiologically and histologically [17, 20].”
BackgroundProgressive multiple sclerosis: from pathogenic mechanisms to treatment
Correale, J., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2016) · Brain · doi:10.1093/brain/aww258 · Cited by 573
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479
Kirk, J., Plumb, J., Mirakhur, M., & McQuaid, S. (2003) · The Journal of Pathology · doi:10.1002/path.1434 · Cited by 375
Regional DTI differences in multiple sclerosis patients
ROOSENDAAL, S., GEURTS, J., VRENKEN, H., HULST, H., COVER, K., CASTELIJNS, J., POUWELS, P., & BARKHOF, F. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.026 · Cited by 370
Luchetti, S., Fransen, N. L., van Eden, C. G., Ramaglia, V., Mason, M., & Huitinga, I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1818-y · Cited by 355
Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging
Haacke, E. M., Makki, M., Ge, Y., Maheshwari, M., Sehgal, V., Hu, J., Selvan, M., Wu, Z., Latif, Z., Xuan, Y., et al. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21676 · Cited by 329
Remyelinated Lesions in Multiple Sclerosis: Magnetic Resonance Image Appearance
Barkhof, F., Brück, W., De Groot, C. J. A., Bergers, E., Hulshof, S., Geurts, J., Polman, C. H., & van der Valk, P. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1073 · Cited by 328
Self-citationPathology of multiple sclerosis and related inflammatory demyelinating diseases
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 303
MACDONALD, C., DIKRANIAN, K., SONG, S., BAYLY, P., HOLTZMAN, D., & BRODY, D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.035 · Cited by 297
High field MRI correlates of myelin content and axonal density in multiple sclerosis
Mottershead, J. P., Schmierer, K., Clemence, M., Thornton, J. S., Scaravilli, F., Barker, G. J., Tofts, P. S., Newcombe, J., Cuzner, M. L., Ordidge, R. J., et al. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0192-3 · Cited by 296
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Marik, C., Felts, P. A., Bauer, J., Lassmann, H., & Smith, K. J. (2007) · Brain · doi:10.1093/brain/awm236 · Cited by 292
Extensive Hippocampal Demyelination in Multiple Sclerosis
Geurts, J. J. G., Bö, L., Roosendaal, S. D., Hazes, T., Daniëls, R., Barkhof, F., Witter, M. P., Huitinga, I., & van der Valk, P. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181461f54 · Cited by 287
Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain
Schmierer, K., Tozer, D. J., Scaravilli, F., Altmann, D. R., Barker, G. J., Tofts, P. S., & Miller, D. H. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20984 · Cited by 273
Smouldering multiple sclerosis: the ‘real MS’
Giovannoni, G., Popescu, V., Wuerfel, J., Hellwig, K., Iacobaeus, E., Jensen, M. B., García-Domínguez, J. M., Sousa, L., De Rossi, N., Hupperts, R., et al. (2022) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211066751 · Cited by 271
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis
Teunissen, C. E., Dijkstra, C., & Polman, C. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00964-0 · Cited by 252
Brink, B. P., Veerhuis, R., Breij, E. C. W., van der Valk, P., Dijkstra, C. D., & Bö, L. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.147 · Cited by 191
Vos, C. M. P., Geurts, J. J. G., Montagne, L., van Haastert, E. S., Bö, L., van der Valk, P., Barkhof, F., & de Vries, H. E. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.012 · Cited by 188
The blood-brain barrier in cortical multiple sclerosis lesions
van Horssen, J., Brink, B. P., de Vries, H. E., van der Valk, P., & Bø, L. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318040b2de · Cited by 187
The role of microglia in multiple sclerosis
Luo, C., Jian, C., Liao, Y., Huang, Q., Wu, Y., Liu, X., Zou, D., & Wu, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s140634 · Cited by 187
Peferoen, L. A. N., Vogel, D. Y. S., Ummenthum, K., Breur, M., Heijnen, P. D. A. M., Gerritsen, W. H., Peferoen-Baert, R. M. B., van der Valk, P., Dijkstra, C. D., & Amor, S. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000149 · Cited by 178
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G. L., & Aloisi, F. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/65.2.124 · Cited by 176
van Horssen, J., Singh, S., van der Pol, S., Kipp, M., Lim, J. L., Peferoen, L., Gerritsen, W., Kooi, E.-J., Witte, M. E., Geurts, J. J., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-156 · Cited by 172
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions
Ambrosini, E., Remoli, M. E., Giacomini, E., Rosicarelli, B., Serafini, B., Lande, R., Aloisi, F., & Coccia, E. M. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000173893.01929.fc · Cited by 161
Preactive lesions in multiple sclerosis
van der Valk, P., & Amor, S. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b4c76 · Cited by 156
Clarner, T., Diederichs, F., Berger, K., Denecke, B., Gan, L., van der Valk, P., Beyer, C., Amor, S., & Kipp, M. (2012) · Glia · doi:10.1002/glia.22367 · Cited by 155
Alvarez, J. I., Saint-Laurent, O., Godschalk, A., Terouz, S., Briels, C., Larouche, S., Bourbonnière, L., Larochelle, C., & Prat, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.016 · Cited by 150
Trapp, B. D., Vignos, M., Dudman, J., Chang, A., Fisher, E., Staugaitis, S. M., Battapady, H., Mork, S., Ontaneda, D., Jones, S. E., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30245-x · Cited by 146
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138
“With a single MRI scan, active, chronic active and inactive lesions cannot be distinguished well, leaving uncertainties regarding the interpretation of a paired TSPO PET scan.”
InfluentialBuschmann, J. P., Berger, K., Awad, H., Clarner, T., Beyer, C., & Kipp, M. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9773-x · Cited by 133
Huitinga, I., Erkut, Z. A., van Beurden, D., & Swaab, D. F. (2004) · Annals of Neurology · doi:10.1002/ana.10766 · Cited by 126
Hypothalamic lesions in multiple sclerosis
Huitinga, I., De Groot, C. J. A., Van der Valk, P., Kamphorst, W., Tilders, F. J. H., & Swaab, D. F. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1208 · Cited by 120
Self-citationImaging of microglia in patients with neurodegenerative disorders
Politis, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00096 · Cited by 111
The formation of inflammatory demyelinated lesions in cerebral white matter
Maggi, P., Macri, S. M. C., Gaitán, M. I., Leibovitch, E., Wholer, J. E., Knight, H. L., Ellis, M., Wu, T., Silva, A. C., Massacesi, L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24242 · Cited by 110
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with18F-PBR111 PET
Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.135129 · Cited by 100
GM‐CSF promotes migration of human monocytes across the blood brain barrier
Vogel, D. Y. S., Kooij, G., Heijnen, P. D. A. M., Breur, M., Peferoen, L. A. N., van der Valk, P., de Vries, H. E., Amor, S., & Dijkstra, C. D. (2015) · European Journal of Immunology · doi:10.1002/eji.201444960 · Cited by 94
Macrosialin increases during normal brain aging are attenuated by caloric restriction
Wong, A. M., Patel, N. V., Patel, N. K., Wei, M., Morgan, T. E., de Beer, M. C., de Villiers, W. J. S., & Finch, C. E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.058 · Cited by 85
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain
Scheld, M., Rüther, B. J., Große-Veldmann, R., Ohl, K., Tenbrock, K., Dreymüller, D., Fallier-Becker, P., Zendedel, A., Beyer, C., Clarner, T., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2456-15.2016 · Cited by 82
Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics
Kilsdonk, I. D., Lopez-Soriano, A., Kuijer, J. P. A., de Graaf, W. L., Castelijns, J. A., Polman, C. H., Luijten, P. R., Geurts, J. J. J. G., Barkhof, F., & Wattjes, M. P. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7351-6 · Cited by 55
Self-citationPeferoen, L. A. N., Breur, M., van de Berg, S., Peferoen‐Baert, R., Boddeke, E. H. W. G. M., van der Valk, P., Pryce, G., van Noort, J. M., Baker, D., & Amor, S. (2016) · Immunology · doi:10.1111/imm.12644 · Cited by 41
Schmierer, K., Scaravilli, F., Barker, G. J., Gordon, R., MacManus, D. G., & Miller, D. H. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00497.x · Cited by 35
Zhan, J., Yakimov, V., Rühling, S., Fischbach, F., Nikolova, E., Joost, S., Kaddatz, H., Greiner, T., Frenz, J., Holzmann, C., et al. (2019) · Cells · doi:10.3390/cells8111439 · Cited by 25
Chrzanowski, U., Bhattarai, S., Scheld, M., Clarner, T., Fallier-Becker, P., Beyer, C., Rohr, S. O., Schmitz, C., Hochstrasser, T., Schweiger, F., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.005 · Cited by 18
Mitochondrial Impairment in Oligodendroglial Cells Induces Cytokine Expression and Signaling
Scheld, M., Fragoulis, A., Nyamoya, S., Zendedel, A., Denecke, B., Krauspe, B., Teske, N., Kipp, M., Beyer, C., & Clarner, T. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1236-6 · Cited by 17
Sun, S.-W., Nishioka, C., Chung, C.-F., Park, J., & Liang, H.-F. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25368 · Cited by 7
Vélez-Uriza, F., Ordaz, R. P., Garay, E., Cisneros-Mejorado, A. J., & Arellano, R. O. (2024) · Scientific Reports · doi:10.1038/s41598-024-64501-x · Cited by 4
Metadata
- Authors
- De Groot, C. J. A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-08-01
- Volume
- 124
- Issue
- 8
- Pages
- 1635-1645
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2280209807
- Cited by
- 285
- References
- 17
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.